A citation-based method for searching scientific literature

Edwin Nieblas-Bedolla, Naema Nayyar, Mohini Singh, Ryan J Sullivan, Priscilla K Brastianos. Oncologist 2021
Times Cited: 6







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Brain metastases.
Achal Singh Achrol, Robert C Rennert, Carey Anders, Riccardo Soffietti, Manmeet S Ahluwalia, Lakshmi Nayak, Solange Peters, Nils D Arvold, Griffith R Harsh, Patricia S Steeg,[...]. Nat Rev Dis Primers 2019
194
66

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Hussein A Tawbi, Peter A Forsyth, Alain Algazi, Omid Hamid, F Stephen Hodi, Stergios J Moschos, Nikhil I Khushalani, Karl Lewis, Christopher D Lao, Michael A Postow,[...]. N Engl J Med 2018
520
50

Brain Metastasis From Renal-Cell Carcinoma: An Institutional Study.
Alfredo Suarez-Sarmiento, Kevin A Nguyen, Jamil S Syed, Adam Nolte, Kamyar Ghabili, Michelle Cheng, Sandy Liu, Veronica Chiang, Harriet Kluger, Michael Hurwitz,[...]. Clin Genitourin Cancer 2019
20
33

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.
Georgina V Long, Uwe Trefzer, Michael A Davies, Richard F Kefford, Paolo A Ascierto, Paul B Chapman, Igor Puzanov, Axel Hauschild, Caroline Robert, Alain Algazi,[...]. Lancet Oncol 2012
607
33

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
Priscilla K Brastianos, Scott L Carter, Sandro Santagata, Daniel P Cahill, Amaro Taylor-Weiner, Robert T Jones, Eliezer M Van Allen, Michael S Lawrence, Peleg M Horowitz, Kristian Cibulskis,[...]. Cancer Discov 2015
489
33

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Sarah B Goldberg, Scott N Gettinger, Amit Mahajan, Anne C Chiang, Roy S Herbst, Mario Sznol, Apostolos John Tsiouris, Justine Cohen, Alexander Vortmeyer, Lucia Jilaveanu,[...]. Lancet Oncol 2016
588
33

Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment.
Justine V Cohen, Ahmed K Alomari, Alexander O Vortmeyer, Lucia B Jilaveanu, Sarah B Goldberg, Amit Mahajan, Veronica L Chiang, Harriet M Kluger. Cancer Immunol Res 2016
86
33

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
33

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
Adel Samson, Karen J Scott, David Taggart, Emma J West, Erica Wilson, Gerard J Nuovo, Simon Thomson, Robert Corns, Ryan K Mathew, Martin J Fuller,[...]. Sci Transl Med 2018
172
33

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.
M B Atkins, M T Lotze, J P Dutcher, R I Fisher, G Weiss, K Margolin, J Abrams, M Sznol, D Parkinson, M Hawkins,[...]. J Clin Oncol 1999
33

Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study.
G A McArthur, M Maio, A Arance, P Nathan, C Blank, M-F Avril, C Garbe, A Hauschild, D Schadendorf, O Hamid,[...]. Ann Oncol 2017
101
33

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.
David J H Shih, Naema Nayyar, Ivanna Bihun, Ibiayi Dagogo-Jack, Corey M Gill, Elisa Aquilanti, Mia Bertalan, Alexander Kaplan, Megan R D'Andrea, Ugonma Chukwueke,[...]. Nat Genet 2020
50
33

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
Nancy U Lin, Virginia Borges, Carey Anders, Rashmi K Murthy, Elisavet Paplomata, Erika Hamilton, Sara Hurvitz, Sherene Loi, Alicia Okines, Vandana Abramson,[...]. J Clin Oncol 2020
101
33

The Evolving Landscape of Brain Metastasis.
Manuel Valiente, Manmeet S Ahluwalia, Adrienne Boire, Priscilla K Brastianos, Sarah B Goldberg, Eudocia Q Lee, Emilie Le Rhun, Matthias Preusser, Frank Winkler, Riccardo Soffietti. Trends Cancer 2018
72
33

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Georgina V Long, Victoria Atkinson, Serigne Lo, Shahneen Sandhu, Alexander D Guminski, Michael P Brown, James S Wilmott, Jarem Edwards, Maria Gonzalez, Richard A Scolyer,[...]. Lancet Oncol 2018
409
33

The biology of brain metastases-translation to new therapies.
April F Eichler, Euiheon Chung, David P Kodack, Jay S Loeffler, Dai Fukumura, Rakesh K Jain. Nat Rev Clin Oncol 2011
299
33

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.
Michael A Davies, Philippe Saiag, Caroline Robert, Jean-Jacques Grob, Keith T Flaherty, Ana Arance, Vanna Chiarion-Sileni, Luc Thomas, Thierry Lesimple, Laurent Mortier,[...]. Lancet Oncol 2017
297
33

Epidemiology of brain metastases.
Lakshmi Nayak, Eudocia Quant Lee, Patrick Y Wen. Curr Oncol Rep 2012
547
33

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Sarah B Goldberg, Kurt A Schalper, Scott N Gettinger, Amit Mahajan, Roy S Herbst, Anne C Chiang, Rogerio Lilenbaum, Frederick H Wilson, Sacit Bulent Omay, James B Yu,[...]. Lancet Oncol 2020
124
33

Elevated C-reactive protein and white blood cell count at admission predict functional outcome after non-aneurysmal subarachnoid hemorrhage.
Patrick Schuss, Alexis Hadjiathanasiou, Simon Brandecker, Ági Güresir, Hartmut Vatter, Erdem Güresir. J Neurol 2018
12
16

Platelet-to-lymphocyte ratio in peripheral blood: A novel independent prognostic factor in patients with melanoma.
Yalong Qi, Yong Zhang, Xiaomin Fu, Axiang Wang, Yonghao Yang, Yiman Shang, Quanli Gao. Int Immunopharmacol 2018
10
16

Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma.
Leonardo S Lino-Silva, Rosa A Salcedo-Hernández, Leticia García-Pérez, Abelardo Meneses-García, César Zepeda-Najar. Melanoma Res 2017
22
16


Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain Metastases.
Matthias Schneider, Muriel Heimann, Christina Schaub, Lars Eichhorn, Anna-Laura Potthoff, Frank A Giordano, Erdem Güresir, Yon-Dschun Ko, Jennifer Landsberg, Felix Lehmann,[...]. Cancers (Basel) 2020
7
16

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition.
Andressa S Laino, David Woods, Melinda Vassallo, Xiaozhong Qian, Hao Tang, Megan Wind-Rotolo, Jeffrey Weber. J Immunother Cancer 2020
34
16

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
16

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
Mehmet A Bilen, Dylan J Martini, Yuan Liu, Colleen Lewis, Hannah H Collins, Julie M Shabto, Mehmet Akce, Haydn T Kissick, Bradley C Carthon, Walid L Shaib,[...]. Cancer 2019
63
16


Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
Kristine H Allin, Børge G Nordestgaard, Henrik Flyger, Stig E Bojesen. Breast Cancer Res 2011
86
16

Factors influencing early postoperative complications following surgery for symptomatic spinal metastasis: a single-center series and multivariate analysis.
Patrick Schuss, Ági Güresir, Matthias Schneider, Markus Velten, Hartmut Vatter, Erdem Güresir. Neurosurg Rev 2020
10
16


Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.
Michael A Postow, Jason Chesney, Anna C Pavlick, Caroline Robert, Kenneth Grossmann, David McDermott, Gerald P Linette, Nicolas Meyer, Jeffrey K Giguere, Sanjiv S Agarwala,[...]. N Engl J Med 2015
16


Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, Catherine Sebban, Axel Le Cesne, Ian Judson, Olivier Tredan, Jaap Verweij, Pierre Biron, Inthidar Labidi,[...]. Cancer Res 2009
424
16

Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer.
Uiju Cho, Hong Sik Park, So Young Im, Chang Young Yoo, Ji Han Jung, Young Jin Suh, Hyun Joo Choi. PLoS One 2018
41
16

Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression.
Marco Papale, Mariachiara Buccarelli, Cristiana Mollinari, Matteo A Russo, Roberto Pallini, Lucia Ricci-Vitiani, Marco Tafani. Int J Mol Sci 2020
15
16

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
Mariaelena Capone, Diana Giannarelli, Domenico Mallardo, Gabriele Madonna, Lucia Festino, Antonio Maria Grimaldi, Vito Vanella, Ester Simeone, Miriam Paone, Giuseppe Palmieri,[...]. J Immunother Cancer 2018
135
16

Immunity, inflammation, and cancer.
Sergei I Grivennikov, Florian R Greten, Michael Karin. Cell 2010
16

Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study.
Ryckie G Wade, Alyss V Robinson, Michelle C I Lo, Claire Keeble, Maria Marples, Donald J Dewar, Marc D S Moncrieff, Howard Peach. Ann Surg Oncol 2018
19
16

Pathogenetic significance and possibility as a therapeutic target of platelet derived growth factor.
Yoko Ishii, Takeru Hamashima, Seiji Yamamoto, Masakiyo Sasahara. Pathol Int 2017
17
16

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study.
Caroline Robert, Antoni Ribas, Jacob Schachter, Ana Arance, Jean-Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona M McNeil, Michal Lotem,[...]. Lancet Oncol 2019
345
16

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Stephen Kaptoge, Emanuele Di Angelantonio, Gordon Lowe, Mark B Pepys, Simon G Thompson, Rory Collins, John Danesh. Lancet 2010
16

Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Arnoud J Templeton, Olga Ace, Mairéad G McNamara, Mustafa Al-Mubarak, Francisco E Vera-Badillo, Thomas Hermanns, Boštjan Seruga, Alberto Ocaña, Ian F Tannock, Eitan Amir. Cancer Epidemiol Biomarkers Prev 2014
343
16

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
Paul W Sperduto, Brian Berkey, Laurie E Gaspar, Minesh Mehta, Walter Curran. Int J Radiat Oncol Biol Phys 2008
628
16

The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.
Graeme J K Guthrie, Kellie A Charles, Campbell S D Roxburgh, Paul G Horgan, Donald C McMillan, Stephen J Clarke. Crit Rev Oncol Hematol 2013
731
16

Prognostic value of the fibrinogen-to-platelet ratio as an inflammatory and coagulative index in patients with gastric cancer.
Kohei Wakatsuki, Sohei Matsumoto, Kazuhiro Migita, Tomohiro Kunishige, Hiroshi Nakade, Shintaro Miyao, Masayuki Sho. Surg Today 2019
5
20

C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.
Shiva Shrotriya, Declan Walsh, Nabila Bennani-Baiti, Shirley Thomas, Cliona Lorton. PLoS One 2015
127
16

Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery.
Mudit Chowdhary, Jeffrey M Switchenko, Robert H Press, Jaymin Jhaveri, Zachary S Buchwald, Philip A Blumenfeld, Gaurav Marwaha, Aidnag Diaz, Dian Wang, Ross A Abrams,[...]. J Neurooncol 2018
22
16

Systemic inflammatory markers as prognostic factors in stage IIA colorectal cancer.
Byung Kwan Park, Ji Won Park, Eon Chul Han, Seung-Bum Ryoo, Sae-Won Han, Tae-You Kim, Eui Kyu Chie, Seung-Yong Jeong, Kyu Joo Park. J Surg Oncol 2016
21
16

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski,[...]. N Engl J Med 2015
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.